NovAccel Raises 1.2 Billion JPY in Post-Seed Round Funding
NQ Score
88/100
N1 Content Completeness
90
AI Summary (NQ-processed)
NovAccel, a developer of small superconducting accelerators for medical radioisotope production, has secured 1.2 billion JPY in a post-seed funding round, bringing its total raised capital to approximately 2.0 billion JPY. The funds will accelerate the establishment of an international radium-226 (Ra-226) procurement system and the completion of its medical radioisotope manufacturing facility by the end of the year, essential for the stable supply of Actinium-225 (Ac-225) for next-generation cancer therapies.